Combined liver and lung transplantation with extended normothermic lung preservation in a patient with end-stage emphysema complicated by drug-induced acute liver failure

American Journal of Transplantation

Volumn 14, Issue 10, 2014, Pages 2412-2416

  Ceulemans, L J ^a,b   Monbaliu, D ^a,b   Verslype, C ^a,b   Van Der Merwe, S ^a,b   Laleman, W ^a,b   Vos, R ^a,b   Neyrinck, A ^a,c   Van Veer, H ^a,b   De Leyn, P ^a,b   Nevens, F ^a,b   Pirenne, J ^a,b   Verleden, G ^a,b   Van Raemdonck, D ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Clinical research; drug toxicity; dysfunction; hepatology; liver (native) function; liver transplantation; lung (allograft) function; lung transplantation; organ perfusion and preservation; organ transplantation in general; practice; pulmonology

Indexed keywords

ISONIAZID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ROXITHROMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE LIVER FAILURE; ADULT; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; EMPHYSEMA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL NORMALIZED RATIO; LATENT TUBERCULOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG; LUNG GRAFT REJECTION; LUNG PERFUSION; LUNG TRANSPLANTATION; MIDDLE AGED; ORGAN PRESERVATION; COMPLICATION; LIVER FAILURE;

EMPHYSEMA; FEMALE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MIDDLE AGED;

EID: 84908230977     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12856     Document Type: Article

References (20)

1. Pirenne J, Verleden G, Nevens F, et al. Combined liver and (heart-)lung transplantation in liver transplant candidates with refractory portopulmonary hypertension. Transplantation 2002; 73: 140-156.
2. Yi SG, Burroughs SG, Loebe M, et al. Combined lung and liver transplantation: Analysis of a single-center experience. Liver Transpl 2014; 20: 46-53.
3. Ichai P, Saliba F, Antoun F, et al. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation. Liver Transpl 2010; 16: 1136-1146.
4. Easton-Carter KL, Hardikar W, Smith AL., Possible roxithromycin-induced fulminant hepatic failure in a child. Pharmacotherapy 2001; 21: 867-870.
5. Pedersen FM, Bathum L, Fenger C., Acute hepatitis and roxithromycin. Lancet 1993; 341: 251-252.
6. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
7. Rana A, Robles S, Russo MJ, et al. The combined organ effect: Protection against injury? Ann Surg 2008; 248: 871-879.
8. Daly RC, Topilsky Y, Joyce L, et al. Combined heart and liver transplantation: Protection of the cardiac graft from antibody rejection by initial liver implantation. Transplantation 2013; 95: e2-e4.
9. Olausson M, Mjörnstedt L, Nordén G, et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007; 7: 130-136.
10. Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L., Transplantation of lungs from a non-heart-beating donor. Lancet 2001; 357: 825-829.
11. Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007; 83: 2191-2195.
12. International Randomized Study of the TransMedics Organ Care System (OCS™ Lung) for Lung Preservation and Transplantation (INSPIRE). Available at: http://clinicaltrials.gov/ct2/show/NCT01630434?term=Inspire&rank=7. Accessed May 19, 2014.
13. Warnecke G, Wiegmann B, Van Raemdonck D, et al. The INSPIRE international lung trial with the Organ Care System Technology (OCS™). J Heart Lung Transplant 2013; 32: S16.
14. Van Raemdonck D, Neyrinck A, Cypel M, Keshavjee S., Ex-vivo lung perfusion. Transpl Int 2014; doi: 10.1111/tri.12317 [Epub ahead of print].
15. Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27: 1319-1325.
16. Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9: 2262-2269.
17. Zych B, Popov AF, Stavri G, et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 2012; 31: 274-281.
18. Cypel M, Yeung JC, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 2012; 144: 1200-1206.
19. Warnecke C, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: A pilot study of 12 patients. Lancet 2012; 380: 1851-1858.
20. Wallinder A, Ricksten SE, Silverborn M, et al. Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: A case-control study. Eur J Cardiothorac Surg 2014; 45: 40-45.